Alpha-0261

Alpha-0261 · AlphaMol Science Ltd. (Shanghai)

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Alpha-0261, covering 2025-12-12 to 2025-12-12. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate Single Doses of Alpha-0261 in Healthy Adult Volunteers [Phase 1]